882235--3/2/2007--LINCARE_HOLDINGS_INC

related topics
{regulation, government, change}
{tax, income, asset}
{cost, regulation, environmental}
{competitive, industry, competition}
{acquisition, growth, future}
Certain Risk Factors Relating to the Company s Business A MAJORITY OF OUR CUSTOMERS HAVE PRIMARY HEALTH COVERAGE UNDER MEDICARE PART B, AND RECENTLY ENACTED AND FUTURE CHANGES IN THE REIMBURSEMENT RATES OR PAYMENT METHODOLOGIES UNDER THE MEDICARE PROGRAM COULD MATERIALLY AND ADVERSELY AFFECT OUR BUSINESS. A SIGNIFICANT PERCENTAGE OF OUR BUSINESS IS DERIVED FROM THE SALE AND RENTAL OF MEDICARE-COVERED OXYGEN AND DME ITEMS, AND RECENT LEGISLATIVE ACTS IMPOSE SUBSTANTIAL CHANGES IN THE MEDICARE PAYMENT METHODOLOGIES AND REDUCTIONS IN THE MEDICARE PAYMENT AMOUNTS FOR THESE ITEMS. A SIGNIFICANT PERCENTAGE OF OUR BUSINESS IS DERIVED FROM THE SALE OF MEDICARE-COVERED RESPIRATORY MEDICATIONS, AND RECENT LEGISLATION IMPOSED SIGNIFICANT REDUCTIONS IN MEDICARE REIMBURSEMENT FOR SUCH INHALATION DRUGS. RECENT REGULATORY CHANGES SUBJECT THE MEDICARE REIMBURSEMENT RATES FOR OUR EQUIPMENT AND SERVICES TO ADDITIONAL REDUCTIONS AND TO POTENTIAL DISCRETIONARY ADJUSTMENT BY CMS, WHICH COULD REDUCE OUR REVENUES, NET INCOME AND CASH FLOWS. RECENT LEGISLATION ESTABLISHING A COMPETITIVE BIDDING PROCESS UNDER MEDICARE COULD REDUCE OUR REVENUES, NET INCOME AND CASH FLOWS. FUTURE REDUCTIONS IN REIMBURSEMENT RATES UNDER MEDICAID COULD REDUCE OUR REVENUES, NET INCOME AND CASH FLOWS. FUTURE REDUCTIONS IN REIMBURSEMENT RATES FROM PRIVATE PAYORS COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR FINANCIAL CONDITION AND OPERATING RESULTS. WE DEPEND UPON REIMBURSEMENT FROM THIRD-PARTY PAYORS FOR A SIGNIFICANT MAJORITY OF OUR REVENUES, AND IF WE FAIL TO MANAGE THE COMPLEX AND LENGTHY REIMBURSEMENT PROCESS, OUR BUSINESS AND OPERATING RESULTS COULD SUFFER. WE ARE SUBJECT TO EXTENSIVE FEDERAL AND STATE REGULATION, AND IF WE FAIL TO COMPLY WITH APPLICABLE REGULATIONS, WE COULD SUFFER SEVERE CRIMINAL OR CIVIL SANCTIONS OR BE REQUIRED TO MAKE SIGNIFICANT CHANGES TO OUR OPERATIONS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR RESULTS OF OPERATIONS. COMPLIANCE WITH REGULATIONS UNDER THE FEDERAL HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 AND RELATED RULES, OR HIPAA, RELATING TO THE TRANSMISSION AND PRIVACY OF HEALTH INFORMATION COULD IMPOSE ADDITIONAL SIGNIFICANT COSTS ON OUR OPERATIONS. WE MAY UNDERTAKE ACQUISITIONS THAT COULD SUBJECT US TO UNANTICIPATED LIABILITIES AND THAT COULD FAIL TO ACHIEVE EXPECTED BENEFITS. WE FACE INTENSE NATIONAL, REGIONAL AND LOCAL COMPETITION AND IF WE ARE UNABLE TO COMPETE SUCCESSFULLY, WE WILL LOSE REVENUES AND OUR BUSINESS WILL SUFFER. INCREASES IN OUR COSTS COULD ERODE OUR PROFIT MARGINS AND SUBSTANTIALLY REDUCE OUR NET INCOME AND CASH FLOWS.

Full 10-K form ▸

related documents
1007330--3/12/2008--PRG_SCHULTZ_INTERNATIONAL_INC
1129623--3/10/2006--ODYSSEY_HEALTHCARE_INC
1139463--12/14/2007--MEDCATH_CORP
1129623--3/14/2008--ODYSSEY_HEALTHCARE_INC
927066--2/28/2007--DAVITA_INC
1139463--12/14/2009--MEDCATH_CORP
1129623--3/10/2010--ODYSSEY_HEALTHCARE_INC
1047335--3/2/2010--NATIONAL_HEALTHCARE_CORP
19411--3/8/2006--MAGELLAN_HEALTH_SERVICES_INC
19411--2/29/2008--MAGELLAN_HEALTH_SERVICES_INC
1051488--7/14/2008--Integrated_Healthcare_Holdings_Inc
1047335--3/17/2008--NATIONAL_HEALTHCARE_CORP
19411--2/27/2009--MAGELLAN_HEALTH_SERVICES_INC
19411--2/26/2010--MAGELLAN_HEALTH_SERVICES_INC
853971--4/17/2006--STANDARD_MANAGEMENT_CORP
882235--2/25/2009--LINCARE_HOLDINGS_INC
882235--2/25/2010--LINCARE_HOLDINGS_INC
882235--2/27/2008--LINCARE_HOLDINGS_INC
803352--9/10/2009--CONTINUCARE_CORP
1179929--3/14/2007--MOLINA_HEALTHCARE_INC
1156039--2/21/2008--WELLPOINT_INC
1156039--2/26/2007--WELLPOINT_INC
1142750--3/13/2006--AMN_HEALTHCARE_SERVICES_INC
896262--2/17/2009--AMEDISYS_INC
1156039--2/19/2009--WELLPOINT_INC
927066--2/25/2010--DAVITA_INC
920052--3/15/2006--RENAL_CARE_GROUP_INC
19584--2/28/2007--CHEMED_CORP
927066--2/29/2008--DAVITA_INC
1018833--3/11/2009--QUADRAMED_CORP